[{"id":"itm","kind":"company","name":"ITM Isotope Technologies Munich","route":"/companies/itm/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/companies.ts","type":"changed","fields":[{"field":"tldr","before":"\"The largest non-carrier-added lutetium-177 supplier and developer of ITM-11 (177Lu-edotreotide).\"","after":"\"ITM is the largest non-carrier-added lutetium-177 supplier and the developer of ITM-11 (177Lu-edotreotide).\""},{"field":"summary","before":"\"n.c.a. 177Lu (EndolucinBeta), ITM-11 (COMPETE phase 3 positive in GEP-NETs, 2025), 225Ac supply investments.\"","after":"\"ITM supplies non-carrier-added 177Lu (EndolucinBeta), developed ITM-11 (COMPETE phase 3 positive in GEP-NETs, 2025), and is investing in 225Ac supply.\""}]},{"id":"itm","kind":"company","name":"ITM Isotope Technologies Munich","route":"/companies/itm/","commit":"815a2a8bae","date":"2026-09-05","author":"Jude Gomila","message":"OnCo: open map of oncology — corpus (642 objects, 14 kinds), graph, static site, API, TNBC spike","file":"src/data/companies.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"hq"},{"field":"country"},{"field":"companyType"},{"field":"website"},{"field":"sections"},{"field":"tldr"},{"field":"summary"},{"field":"targets"}]}]